Pharmaceutical stocks are expected to rise on Monday morning, after Roche and GlaxoSmithKline said they may need to supply millions of vaccine doses to help protect against the swine flu that has killed up to 81 people in Mexico.
Vaccines from Roche, which sells Tamiflu, and GSK, maker of Relenza, have been shown to work against viral samples of the new disease. The drugs were also used to help protect against outbreaks of bird flu in Asia, providing windfall profits for the companies.
Roche confirmed it already has a stockpile of 3m packs of Tamiflu ready for use by the World Health Organisation (WHO).
For the rest of the article, go here.